Tax-loss harvesting alternatives for PRGO

Among the 30 Pharmaceuticals peers screened, SUPN (Supernus Pharmaceuticals, Inc.) has tracked PRGO most closely over the past year, with a return correlation of 0.45. The strongest fund stand-in is XHE (SPDR S&P Health Care Equipment) at 0.36 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →

STOCKS

Single-name peers

Ticker	Name	Sub-industry	1Y	3Y	5Y	10Y
SUPN	Supernus Pharmaceuticals, Inc.	Pharmaceuticals	0.45	0.24	0.25	0.23
ELAN	Elanco	Pharmaceuticals	0.37	0.29	0.30	0.31
PBH	Prestige Consumer Healthcare	Pharmaceuticals	0.35	0.32	0.29	0.29
SNY	Sanofi S.A.	Pharmaceuticals	0.28	0.24	0.23	0.25
ZTS	Zoetis Inc.	Pharmaceuticals	0.27	0.24	0.27	0.27
AZN	AstraZeneca	Pharmaceuticals	0.27	0.23	0.23	0.22
AMPH	Amphstar Pharmaceuticals, Inc.	Pharmaceuticals	0.24	0.20	0.21	0.23
VTRS	Viatris	Pharmaceuticals	0.22	0.28	0.29	0.37
PFE	Pfizer Inc.	Pharmaceuticals	0.22	0.26	0.21	0.28
PAHC	Phibro Animal Health	Pharmaceuticals	0.22	0.22	0.23	0.23
MRK	Merck & Co.	Pharmaceuticals	0.21	0.22	0.21	0.25
ANIP	ANI Pharmaceuticals, Inc.	Pharmaceuticals	0.21	0.23	0.21	0.28
COLL	Collegium Pharmaceutical, Inc.	Pharmaceuticals	0.20	0.20	0.20	0.24
GSK	GSK plc	Pharmaceuticals	0.20	0.18	0.18	0.23
AMRX	Amneal Pharmaceuticals	Pharmaceuticals	0.19	0.24	0.22	0.25
LLY	Eli Lilly	Pharmaceuticals	0.18	0.16	0.18	0.22
INDV	Indivior	Pharmaceuticals	0.18	0.12	-0.01	0.00
NVO	Novo Nordisk	Pharmaceuticals	0.14	0.14	0.17	0.19
ACAD	Acadia Pharmaceuticals	Pharmaceuticals	0.14	0.20	0.18	0.19
JNJ	Johnson & Johnson	Pharmaceuticals	0.11	0.18	0.20	0.27
ALKS	Alkermes plc	Pharmaceuticals	0.11	0.20	0.20	0.24
OGN	Organon & Co.	Pharmaceuticals	0.11	0.18	0.22	—
INVA	Innoviva, Inc.	Pharmaceuticals	0.09	0.16	0.18	0.20
BMY	Bristol-Myers Squibb	Pharmaceuticals	0.09	0.19	0.19	0.25
JAZZ	Jazz Pharmaceuticals	Pharmaceuticals	0.07	0.17	0.19	0.26
ABBV	AbbVie Inc.	Pharmaceuticals	0.07	0.14	0.15	0.22
LQDA	Liquidia Corporation	Pharmaceuticals	0.06	0.08	0.10	0.10
CORT	Corcept Therapeutics Incorporated	Pharmaceuticals	0.02	0.05	0.07	0.12
PTCT	PTC Therapeutics, Inc.	Pharmaceuticals	0.01	0.19	0.18	0.15
PCRX	Pacira BioSciences, Inc.	Pharmaceuticals	-0.02	0.07	0.12	0.19

ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

Ticker	Name	Focus	Match	1Y	3Y	5Y	10Y
XHE	SPDR S&P Health Care Equipment	Medical Devices (Equal Wt)	SUB-IND	0.36	0.36	0.35	0.36
IHI	iShares Medical Devices ETF	Medical Devices	SUB-IND	0.34	0.32	0.34	0.35
FHLC	Fidelity MSCI Health Care ETF	Health Care Sector	SECTOR	0.33	0.37	0.37	0.41
IYH	iShares US Healthcare ETF	Health Care Sector	SECTOR	0.33	0.36	0.36	0.41
VHT	Vanguard Health Care ETF	Health Care Sector	SECTOR	0.33	0.36	0.37	0.41
XLV	Health Care Select Sector SPDR	Health Care Sector	SECTOR	0.32	0.35	0.36	0.40
XPH	SPDR S&P Pharmaceuticals	Pharmaceuticals (Equal Wt)	INDUSTRY	0.29	0.37	0.39	0.47
IHE	iShares US Pharmaceuticals ETF	Pharmaceuticals	INDUSTRY	0.28	0.35	0.37	0.45
PPH	VanEck Pharma ETF	Pharmaceuticals	INDUSTRY	0.27	0.32	0.36	0.47
IBB	iShares Biotechnology ETF	Biotechnology	INDUSTRY	0.26	0.32	0.32	0.37
IHF	iShares Health Care Providers	Health Care Providers	INDUSTRY	0.20	0.23	0.26	0.33
XBI	SPDR S&P Biotech ETF	Biotechnology (Equal Wt)	INDUSTRY	0.20	0.27	0.27	0.32

NEXT STEPS

Harvesting a loss in PRGO?

Estimate what the harvest could save →Check the eight wash-sale traps →Document the trade with a Tax Memo →

Replacement research for PRGO's peers

SUPN ELAN PBH SNY ZTS AZN AMPH VTRS PFE PAHC MRK ANIP COLL GSK AMRX LLY INDV NVO ACAD JNJ ALKS OGN INVA BMY JAZZ ABBV LQDA CORT PTCT PCRX

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.